CA2244576C - Dispositif d'inhalation - Google Patents
Dispositif d'inhalation Download PDFInfo
- Publication number
- CA2244576C CA2244576C CA 2244576 CA2244576A CA2244576C CA 2244576 C CA2244576 C CA 2244576C CA 2244576 CA2244576 CA 2244576 CA 2244576 A CA2244576 A CA 2244576A CA 2244576 C CA2244576 C CA 2244576C
- Authority
- CA
- Canada
- Prior art keywords
- hold
- chamber
- air
- inhalation device
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000126 substance Substances 0.000 claims abstract description 151
- 238000004891 communication Methods 0.000 claims abstract description 21
- 239000003814 drug Substances 0.000 claims description 40
- 210000004072 lung Anatomy 0.000 description 24
- 235000014748 Amaranthus tricolor Nutrition 0.000 description 11
- 244000024893 Amaranthus tricolor Species 0.000 description 11
- 235000010725 Vigna aconitifolia Nutrition 0.000 description 11
- 239000002245 particle Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 230000013011 mating Effects 0.000 description 5
- 238000005243 fluidization Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 230000003434 inspiratory effect Effects 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- 229960000265 cromoglicic acid Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003108 brompheniramine maleate Drugs 0.000 description 1
- SRGKFVAASLQVBO-BTJKTKAUSA-N brompheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 SRGKFVAASLQVBO-BTJKTKAUSA-N 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940085861 flovent Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940070384 ventolin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nozzles (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2244576 CA2244576C (fr) | 1997-08-07 | 1998-08-04 | Dispositif d'inhalation |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,212,430 | 1997-08-07 | ||
| CA002212430A CA2212430A1 (fr) | 1997-08-07 | 1997-08-07 | Appareil inhalateur |
| CA 2244576 CA2244576C (fr) | 1997-08-07 | 1998-08-04 | Dispositif d'inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2244576A1 CA2244576A1 (fr) | 1999-02-07 |
| CA2244576C true CA2244576C (fr) | 2008-02-05 |
Family
ID=25679527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2244576 Expired - Fee Related CA2244576C (fr) | 1997-08-07 | 1998-08-04 | Dispositif d'inhalation |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2244576C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114949483B (zh) * | 2021-02-23 | 2024-02-20 | 苏州易合医药有限公司 | 一种干粉吸入器及其制造方法 |
-
1998
- 1998-08-04 CA CA 2244576 patent/CA2244576C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2244576A1 (fr) | 1999-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6116239A (en) | Inhalation device | |
| US5239993A (en) | Dosage inhalator providing optimized compound inhalation trajectory | |
| US5435301A (en) | Powder inhaler having dispersing, discharge, and dwell-time chambers, along with an acceleration channel | |
| US7025056B2 (en) | Assymetric inhaler | |
| CN1859938B (zh) | 单位剂量的药筒和干粉吸入器 | |
| US5186166A (en) | Powder nebulizer apparatus and method of nebulization | |
| US8550070B2 (en) | Powder inhaler | |
| KR100321814B1 (ko) | 건분말흡입기 | |
| EP1328310B1 (fr) | Inhalateur a poudre seche | |
| US6810874B1 (en) | Powder inhaler for combined medicament | |
| US20040211419A1 (en) | Inhalers | |
| JPH07500996A (ja) | 吸入器 | |
| JPH08502904A (ja) | 低流量ネブライザ、噴霧化方法及び装置 | |
| IE45837B1 (en) | Device for use with pressurised aerosol type medicinal inhalation devices | |
| AU2309192A (en) | Method and device for delivering aerosolized medicaments | |
| RU16905U1 (ru) | Насадка, используемая при пероральной ингаляции лекарственными средствами в виде аэрозоля | |
| CA2244576C (fr) | Dispositif d'inhalation | |
| EP2157990B1 (fr) | Inhalateur pour une administration de médicament pulvérulent | |
| WO2007068341A1 (fr) | Masque pour thérapie par aérosol | |
| AU2002341219A1 (en) | Inhalers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |